Prologue: 2014 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Abstract

The 2014 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) was held in New York, New York, USA, and attended by rheumatologists, dermatologists, and representatives of biopharmaceutical companies and patient groups. Summaries of presentations at that meeting are introduced, including the GRAPPA-organized Fellows Symposium adjacent to the 2014 Swiss Psoriasis Day in Geneva. At the GRAPPA meeting itself, a Trainees Symposium was organized for rheumatology fellows and dermatology residents to present their research work; several patient research partners (PRP) organized Building Bridges, a session of interactive dialogue regarding the roles and responsibilities of PRP and researchers participating in working groups at GRAPPA and elsewhere; and 5 dermatology sessions were held to report on the international dermatology outcome measures group. Among the meeting topics were dermatologists' management of psoriatic arthritis (PsA); the unmet need for a comprehensive assessment tool for psoriasis; the Psoriasis Symptom Inventory; and the importance of treat-to-target strategies for managing psoriasis. Other presentations included an update of GRAPPA's research initiative to develop evidence-based criteria to identify inflammatory arthritis, enthesitis, dactylitis, and spondylitis; the utility of magnetic resonance imaging in PsA; a review of the PsA working group at OMERACT (Outcome Measures in Rheumatology); and updates on several GRAPPA educational projects. Considerable time was allotted to discussions of GRAPPA's efforts to update its treatment guidelines for PsA. (

Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

“…Reports of previous annual meetings have been published elsewhere. [1][2][3][4][5][6][7][8][9][10][11][12] As is customary, the meeting kicked off with the GRAPPA trainee symposium. This session consisted of 5 presentations by rheumatology and dermatology trainees and included the following topics: prediction of cardiovascular events in psoriatic disease (PsD), correlation between spine abnormalities and clinical findings, biomechanical stress as a trigger for psoriatic arthritis (PsA), differences in DNA methylation among twins with PsD, and critical proteins associated with induction of PsD.…”

Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

“…Currently, there are 981 international GRAPPA members, including investigators in rheumatology and dermatology (n = 673), representatives of biopharmaceutical companies (n = 212), PRP (n = 27), and other members (n = 69). Reports of previous yearly meetings have been published elsewhere [1][2][3][4][5][6][7][8][9][10] .…”

Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

“…Currently, there are 951 worldwide GRAPPA members, including investigators in rheumatology and dermatology (n = 650), representatives of biopharmaceutical companies (n = 207), PRP (n = 12), and other members (n = 82). Reports of previous yearly meetings have been published elsewhere 1,2,3,4,5,6,7,8,9 .…”